|
|
Volumn 9, Issue SPEC. ISS. 1, 2001, Pages 41-48
|
|
Pharmacological and pharmacokinetic properties of piribedil: Rationale for use in Parkinson's disease;Propriétés pharmacologiques et pharmacocinétiques du piribédil: Logique de son utilisation dans le traitement de la maladie de Parkinson
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 (3,4 DIHYDROXYBENZYL) 4 (2 PYRIMIDINYL)PIPERAZINE;
1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;
APOMORPHINE;
BROMOCRIPTINE;
CABERGOLINE;
DOPAMINE 1 RECEPTOR;
DOPAMINE 2 RECEPTOR;
DOPAMINE 3 RECEPTOR;
DOPAMINE RECEPTOR STIMULATING AGENT;
DRUG METABOLITE;
LEVODOPA;
LISURIDE;
OXIDOPAMINE;
PERGOLIDE;
PIRIBEDIL;
PRAMIPEXOLE;
ROPINIROLE;
UNCLASSIFIED DRUG;
CELL PROTECTION;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG METABOLISM;
HUMAN;
MONKEY;
MOTOR DYSFUNCTION;
NERVE CELL NECROSIS;
NONHUMAN;
PARKINSON DISEASE;
REVIEW;
|
|
EID: 19244384848
PISSN: 11738790
EISSN: None
Source Type: Journal
DOI: 10.2165/00115677-200109991-00005 Document Type: Review |
|
Times cited : (7)
|
|
References (39)
|
